Oculoplastic and ocular surface morbidity after medication-first therapy versus selective laser trabeculoplasty: A 6-year analysis of the LiGHT trial

PurposeLong-term topical glaucoma medication may contribute to ocular surface and oculoplastic morbidity. This study compared ocular morbidity after medication-first versus selective laser trabeculoplasty (SLT)-first therapy over six years in the LiGHT Trial.MethodsThis post hoc secondary analysis used adverse-event and quality-of-life data from the 6-year LiGHT Trial extension cohort. Patients were grouped by randomised strategy (SLT-first or medication-first); the SLT-first arm was subdivided into those who later received medication and those who remained medication-free. Adverse events were categorised as ocular surface disease, oculoplastic changes, or surgical intervention, compared by logistic regression adjusted for age and sex. Quality-of-life change was assessed with mixed-effects models.ResultsA total of 633 patients were included: 313 SLT-first and 320 medication-first. Ocular surface disease was more frequent in the medication-first arm than in the SLT-first arm (65.3% vs 51.8%; OR 1.75, 95% CI 1.27-2.41; p = 0.001), as were oculoplastic changes (33.4% vs 17.9%; OR 2.30, 95% CI 1.59-3.35; p < 0.001). Surgical intervention rates were similar. Within the SLT-first arm, patients who later required medication had higher morbidity than those who remained medication-free.ConclusionsMedication-first therapy was associated with greater ocular surface and oculoplastic morbidity than SLT-first therapy. Findings should be interpreted as treatment-strategy effects rather than isolated prostaglandin-specific effects.

Authors

Institutions

Publication Details

Journal
European Journal of Ophthalmology
Published
2026-11-12
DOI
https://doi.org/10.1177/11206721261505024
Primary Topic
Glaucoma and retinal disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Oculoplastic and ocular surface morbidity after medication-first therapy versus selective laser trabeculoplasty: A 6-year analysis of the LiGHT trial

Gus Gazzard, Meydan Ben Ishai, C. Schulz, Grace Nicol
European Journal of Ophthalmology
Glaucoma and retinal disorders
article

Oculoplastic and ocular surface morbidity after medication-first therapy versus selective laser trabeculoplasty: A 6-year analysis of the LiGHT trial

Gus Gazzard, Meydan Ben Ishai, C. Schulz, Grace Nicol
article en

Abstract

PurposeLong-term topical glaucoma medication may contribute to ocular surface and oculoplastic morbidity. This study compared ocular morbidity after medication-first versus selective laser trabeculoplasty (SLT)-first therapy over six years in the LiGHT Trial.MethodsThis post hoc secondary analysis used adverse-event and quality-of-life data from the 6-year LiGHT Trial extension cohort. Patients were grouped by randomised strategy (SLT-first or medication-first); the SLT-first arm was subdivided into those who later received medication and those who remained medication-free. Adverse events were categorised as ocular surface disease, oculoplastic changes, or surgical intervention, compared by logistic regression adjusted for age and sex. Quality-of-life change was assessed with mixed-effects models.ResultsA total of 633 patients were included: 313 SLT-first and 320 medication-first. Ocular surface disease was more frequent in the medication-first arm than in the SLT-first arm (65.3% vs 51.8%; OR 1.75, 95% CI 1.27-2.41; p = 0.001), as were oculoplastic changes (33.4% vs 17.9%; OR 2.30, 95% CI 1.59-3.35; p < 0.001). Surgical intervention rates were similar. Within the SLT-first arm, patients who later required medication had higher morbidity than those who remained medication-free.ConclusionsMedication-first therapy was associated with greater ocular surface and oculoplastic morbidity than SLT-first therapy. Findings should be interpreted as treatment-strategy effects rather than isolated prostaglandin-specific effects.

European Journal of Ophthalmology
Moorfields Eye Hospital NHS Foundation Trust (GB), Tel Aviv University (IL), Rabin Medical Center (IL), Portsmouth Hospitals NHS Trust (GB)
Good health and well-being
Glaucoma and retinal disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon